Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice.
Hacker, M
Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice. [electronic resource] - European journal of nuclear medicine and molecular imaging Mar 2012 - 396-8 p. digital
Publication Type: Editorial; Comment
1619-7089
10.1007/s00259-011-2027-2 doi
Abdominal Fat--drug effects
Anti-Inflammatory Agents--pharmacology
Arteritis--drug therapy
Atorvastatin
Female
Heptanoic Acids--pharmacology
Humans
Male
Pyrroles--pharmacology
Vascular Calcification--drug therapy
Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice. [electronic resource] - European journal of nuclear medicine and molecular imaging Mar 2012 - 396-8 p. digital
Publication Type: Editorial; Comment
1619-7089
10.1007/s00259-011-2027-2 doi
Abdominal Fat--drug effects
Anti-Inflammatory Agents--pharmacology
Arteritis--drug therapy
Atorvastatin
Female
Heptanoic Acids--pharmacology
Humans
Male
Pyrroles--pharmacology
Vascular Calcification--drug therapy